Talkspace (NASDAQ:TALK – Get Free Report) and Nyxoah (NASDAQ:NYXH – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.
Institutional & Insider Ownership
57.4% of Talkspace shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares Talkspace and Nyxoah”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Talkspace | $228.87 million | 3.81 | $7.79 million | $0.01 | 520.00 |
| Nyxoah | $11.33 million | 5.88 | -$101.92 million | ($2.48) | -0.69 |
Talkspace has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Talkspace has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations and price targets for Talkspace and Nyxoah, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Talkspace | 1 | 7 | 1 | 0 | 2.00 |
| Nyxoah | 1 | 1 | 2 | 0 | 2.25 |
Talkspace presently has a consensus target price of $5.56, indicating a potential upside of 6.97%. Nyxoah has a consensus target price of $7.00, indicating a potential upside of 306.98%. Given Nyxoah’s stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Talkspace.
Profitability
This table compares Talkspace and Nyxoah’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Talkspace | 0.49% | 1.03% | 0.88% |
| Nyxoah | -543.21% | -163.73% | -80.24% |
Summary
Talkspace beats Nyxoah on 9 of the 14 factors compared between the two stocks.
About Talkspace
Talkspace, Inc. operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists. The company offers Talkspace Employee Assistance Program (EAP) and Talkspace Behavioral Health plan (BH) that provides online therapy to members through BH and EAP offerings; and Talkspace for Business for members to access its platform services on a benefit plan paid by the enterprise. It serves its platform through third-party platforms or marketplace, such as Apple App Store and Google Play App Store. Talkspace, Inc. was founded in 2012 and is headquartered in New York, New York.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Receive News & Ratings for Talkspace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talkspace and related companies with MarketBeat.com's FREE daily email newsletter.
